1. Home
  2. NFGC vs MNPR Comparison

NFGC vs MNPR Comparison

Compare NFGC & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NFGC
  • MNPR
  • Stock Information
  • Founded
  • NFGC 2016
  • MNPR 2014
  • Country
  • NFGC Canada
  • MNPR United States
  • Employees
  • NFGC N/A
  • MNPR N/A
  • Industry
  • NFGC Precious Metals
  • MNPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NFGC Basic Materials
  • MNPR Health Care
  • Exchange
  • NFGC Nasdaq
  • MNPR Nasdaq
  • Market Cap
  • NFGC 261.0M
  • MNPR 209.3M
  • IPO Year
  • NFGC N/A
  • MNPR 2019
  • Fundamental
  • Price
  • NFGC $1.52
  • MNPR $36.87
  • Analyst Decision
  • NFGC Strong Buy
  • MNPR Strong Buy
  • Analyst Count
  • NFGC 1
  • MNPR 7
  • Target Price
  • NFGC $5.00
  • MNPR $62.00
  • AVG Volume (30 Days)
  • NFGC 635.8K
  • MNPR 60.7K
  • Earning Date
  • NFGC 08-08-2025
  • MNPR 08-08-2025
  • Dividend Yield
  • NFGC N/A
  • MNPR N/A
  • EPS Growth
  • NFGC N/A
  • MNPR N/A
  • EPS
  • NFGC N/A
  • MNPR N/A
  • Revenue
  • NFGC N/A
  • MNPR N/A
  • Revenue This Year
  • NFGC N/A
  • MNPR N/A
  • Revenue Next Year
  • NFGC N/A
  • MNPR N/A
  • P/E Ratio
  • NFGC N/A
  • MNPR N/A
  • Revenue Growth
  • NFGC N/A
  • MNPR N/A
  • 52 Week Low
  • NFGC $0.93
  • MNPR $1.72
  • 52 Week High
  • NFGC $3.65
  • MNPR $54.30
  • Technical
  • Relative Strength Index (RSI)
  • NFGC 45.76
  • MNPR 52.95
  • Support Level
  • NFGC $1.34
  • MNPR $31.84
  • Resistance Level
  • NFGC $1.47
  • MNPR $42.00
  • Average True Range (ATR)
  • NFGC 0.06
  • MNPR 2.66
  • MACD
  • NFGC -0.02
  • MNPR 0.57
  • Stochastic Oscillator
  • NFGC 15.38
  • MNPR 52.62

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: